Impact of patient’s socioeconomic status on drug prescribing decisions among physicians: a qualitative analysis
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20261958Keywords:
Socioeconomic status, Prescribing practices, Generic drugs, Healthcare accessibility, PharmacoeconomicsAbstract
Background: A qualitative descriptive study was conducted among 50 physicians from public and private healthcare sectors using purposive sampling. Data was collected through semi-structured, open-ended interviews to explore physician’s views on how patient socioeconomic status (SES) influences prescribing patterns. Responses were analyzed thematically to identify key determinants and strategies used by physician’s to address socioeconomic disparities.
Methods: A qualitative descriptive study was conducted among 50 physicians from public and private healthcare sectors using purposive sampling. Data was collected through semi-structured, open-ended interviews to explore physician’s views on how patient SES influences prescribing patterns. Responses were analyzed thematically to identify key determinants and strategies used by physician’s to address socioeconomic disparities.
Results: Physicians widely acknowledged SES as a major determinant of prescribing decisions with affordability influencing drug selection, dosage and treatment duration especially in chronic and elective care. Common adaptive strategies included prescribing cost-effective regimens, providing free samples, and referring patients to government schemes such as Jan Aushadhi and NPCBVI. While most physicians recognized the affordability benefits of generic drugs, scepticism regarding their bioavailability and clinical efficacy persisted. Ethical and emotional strain was evident, particularly when physicians had to balance optimal therapy with patients’ financial constraints. Emergency and critical care prescribing remained largely SES neutral.
Conclusions: Patient’s SES significantly shapes prescribing decisions in non-emergency contexts. Enhancing access to affordable medicines, strengthening trust in generics through regulatory oversight, and integrating pharmacoeconomic and socioeconomic sensitivity training into medical education are essential to promote equitable, patient-centered prescribing practices.
Metrics
References
Corrick F, Conroy S, Sammons H, Choonara I. Paediatric rational prescribing: A systematic review of assessment tools. Int J Environ Res Public Health. 2020;17(5):1473. DOI: https://doi.org/10.3390/ijerph17051473
Fereydooni S, Lorenz K, Azarfar A, Luckett T, Phillips JL, Becker W, et al. Identifying provider, patient and practice factors that shape long-term opioid prescribing for cancer pain: a qualitative study of American and Australian providers. BMJ Open. 2024;14(3):e082033. DOI: https://doi.org/10.1136/bmjopen-2023-082033
McMaughan DJ, Oloruntoba O, Smith ML. Socioeconomic status and access to healthcare: Interrelated drivers for healthy aging. Front Public Health. 2020;8:231. DOI: https://doi.org/10.3389/fpubh.2020.00231
Wilder ME, Kulie P, Jensen C, Levett P, Blanchard J, Dominguez LW, et al. The impact of social determinants of health on medication adherence: A systematic review and meta-analysis. J Gen Intern Med. 2021;36(5):1359-70. DOI: https://doi.org/10.1007/s11606-020-06447-0
Kalita A, Carton-Rossen N, Joseph L, Chhetri D, Patel V. The barriers to Universal Health Coverage in India and the strategies to address them: A key informant study. Ann Glob Health. 2023;89(1):69. DOI: https://doi.org/10.5334/aogh.4120
Ghinea N, Hutchison K, Lotz M, Rogers WA. Cost-related non-adherence to prescribed medicines: What are physicians’ moral duties? Am J Bioeth. 2025;25(8):111-22.
Alnijadi AA, Yuan J, Wu J, Li M, Lu ZK. Cost-related medication nonadherence (CRN) on healthcare utilization and patient-reported outcomes: Considerations in managing Medicare beneficiaries on antidepressants. Front Pharmacol. 2021;12:764697. DOI: https://doi.org/10.3389/fphar.2021.764697
Gómez Abreo D, Alarcón Cano DF, Ayala F, Belalcázar Carvajal N, Berrouet Mejía MC, Beltrán O, et al. Optimization of the use of generic medications in oncology: Improving safety and therapeutic quality. J Clin Med. 2025;14(21):7543. DOI: https://doi.org/10.3390/jcm14217543
Galappatthy P, Ranasinghe P, Liyanage CK, Wijayabandara M, Warapitiya DS, Jayasekara D, et al. Core prescribing indicators and the most commonly prescribed medicines in a tertiary health care setting in a developing country. Adv Pharmacol Pharm Sci. 2021;2021:6625377. DOI: https://doi.org/10.1155/2021/6625377
Job C, Adenipekun B, Cleves A, Gill P, Samuriwo R. Health professionals implicit bias of patients with low socioeconomic status (SES) and its effects on clinical decision-making: a scoping review. BMJ Open. 2024;14(7):e081723. DOI: https://doi.org/10.1136/bmjopen-2023-081723
Chelak K, Chakole S. The role of social determinants of health in promoting health equality: A narrative review. Cureus. 2023;15(1):e33425. DOI: https://doi.org/10.7759/cureus.33425
Braveman P, Gottlieb L. The Social Determinants of health: It’s time to consider the causes of the causes. Public Health Rep. 2014;129(1-2):19-31. DOI: https://doi.org/10.1177/00333549141291S206
Santra S, Rath K, Mishra SS, Sharma K, Sharma K. Study of influencing factors on drug prescribing behavior of practitioners in an urban city of eastern India. Int J Pharmaceut Clin Res. 2022;14(5):517-24.
Yenet A, Nibret G, Tegegne BA. Challenges to the availability and affordability of essential medicines in African countries: A scoping review. Clinicoecon Outcomes Res. 2023;15:443-58. DOI: https://doi.org/10.2147/CEOR.S413546
Bala MB, Balamurugan S, Gopal M. An empirical assessment of Out-of-pocket healthcare expenditure and financial vulnerability in Southern India: A cross-sectional survey study. Academic Med Surg. 2025;1-5. DOI: https://doi.org/10.62186/001c.144500
Bomhof CHC, Schermer M, Sleijfer S, Bunnik EM. Physicians’ perspectives on ethical issues regarding expensive anti-cancer treatments: A qualitative study. AJOB Empir Bioeth. 2022;13(4):275-86. DOI: https://doi.org/10.1080/23294515.2022.2110963
Selvaraj S, Farooqui HH, Karan A. Quantifying the financial burden of households’ out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994-2014. BMJ Open. 2018;8(5):e018020. DOI: https://doi.org/10.1136/bmjopen-2017-018020
Patel V, Mazumdar-Shaw K, Kang G, Das P, Khanna T. Reimagining India’s health system: a Lancet Citizens’ Commission. Lancet. 2021;397(10283):1427-30. DOI: https://doi.org/10.1016/S0140-6736(20)32174-7
Toverud E-L, Hartmann K, Håkonsen H. A systematic review of physicians’ and pharmacists’ perspectives on generic drug use: What are the global challenges? Appl Health Econ Health Policy. 2015;13(1):S35-45. DOI: https://doi.org/10.1007/s40258-014-0145-2
Aivalli PK, Elias MA, Pati MK, Bhanuprakash S, Munegowda C, Shroff ZC, et al. Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India. BMJ Glob Health. 2017;2(3):e000644. DOI: https://doi.org/10.1136/bmjgh-2017-000644
Balan B, Bakthavatchalam S. Study on impact of pharmacology teaching on practice of self-medication among MBBS students. Int J Basic Clin Pharmacol. 2020;9(3):487. DOI: https://doi.org/10.18203/2319-2003.ijbcp20200727
DeBoer RJ, Mutoniwase E, Nguyen C, Ho A, Umutesi G, Nkusi E, et al. Moral distress and resilience associated with cancer care priority setting in a resource-limited context. Oncologist. 2021;26(7):e1189-96. DOI: https://doi.org/10.1002/onco.13818
Ghinea N, Hutchison K, Lotz M, Rogers WA. Cost-related non-adherence to prescribed medicines: What are physicians’ moral duties? Am J Bioeth. 2025;25(8):111-22. DOI: https://doi.org/10.1080/15265161.2024.2337408
Downloads
Published
How to Cite
Issue
Section
